Lynn B. Oertel

Learn More
Venous thromboembolism (VTE) is a serious medical condition associated with significant morbidity and mortality, and an incidence that is expected to double in the next forty years. The advent of direct oral anticoagulants (DOACs) has catalyzed significant changes in the therapeutic landscape of VTE treatment. As such, it is imperative that clinicians(More)
To test the hypothesis that atrial enlargement can develop as a consequence of atrial fibrillation, left and right atrial dimensions were measured echocardiographically at two different time points in patients with atrial fibrillation. Patients were selected who initially had normal atrial sizes and who had no evidence of significant structural or(More)
BACKGROUND While anticoagulation clinics have been shown to deliver tailored, high-quality care to patients receiving warfarin therapy, communication barriers with limited English proficient (LEP) patients may lead to disparities in anticoagulation outcomes. METHODS AND RESULTS We analyzed data on 3770 patients receiving care from the Massachusetts(More)
BACKGROUND AND PURPOSE The Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) demonstrated that low-intensity warfarin anticoagulation can, with safety, sharply reduce the rate of stroke in patients with nonvalvular atrial fibrillation. The beneficial effect of warfarin was presumably related to a decrease in clot formation in the cardiac(More)
Symptomatic cerebral vasospasm following subarachnoid hemorrhage from ruptured saccular aneurysms is a major factor in the neurologic deterioration of these patients. Many therapeutic interventions have been proposed to treat this cerebral vasospasm; however, the most effective means to counteract this development still eludes the health care team. Faced(More)
  • 1